EnviroTech :: R&D
Novartis to Invest $1 Billion on R&D Center in China; Opens $250-Million API Site at Changshu
4:51 AM MST | November 3, 2009 | Deepti Ramesh
Novartis says it will invest $1 billion over the next five years, to increase pharmaceutical research and development (R&D) activities in China. The investment will involve a significant expansion of the Novartis Institute of BioMedical Research (CNIBR) at Shanghai, the company says. Novartis says it has also invested $250 million in a new technical center at Changshu, China, which opened this week, and the center is focused on technical research, development and manufacturing of active pharmaceutical ingredients (APIs). The facility is expected to be a...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee